WebMD and Reckitt Benckiser launch new cold and flu chatbot

This season, WebMD and Parsippany, N.J.-based Reckitt Benckiser are expanding their partnership with a new cold and flu chatbot designed to allow for more timely, targeted and personal connections with consumers.



The AI device provides an additional way for RB to gain actionable information on consumer behavior and it provides WebMD’s users with a more interactive way of receiving credible, actionable and “snackable” health information.

 

Consumers will find the bot on the lower right corner of the WebMD’s Cold and Flu Map. They’ll be able to ask the bot questions about their symptoms and receive answers from WebMD’s symptom checker database.



Within the Map, alongside the chatbot, RB will have geo-targeted marketing of products  (i.e. Airborne, Mucinex and Lysol) based on symptoms being reported in those customers’ zip codes.



For the past six years, WebMD and RB have positioned themselves at the forefront of cold and flu season. WebMD’s popular "Symptom Checker"  gets more than  4 million searches a month and powers WebMD’s Cold and Flu Map.